There is no way Mason can put this to rest. If he does, what else can he occupy his time with? I mean compare IMU with RAC. IMU trials progresses in leaps and bounds. So much to learn and analyse. We got Vaxinia in both mono and combo trials. OnCarlytics in both mono and combo trials. News, news, news galore really when compared to all other research biotech.
What has Mason's beloved RAC got? Oh yes, bisantrene can swim freestyle and backstroke and it has been around for yonks and analysed to death. Boring! So much so that its CEO is also spending lots and lots of time in Hotcopper. I mean seriously. If RAC has as much happening as IMU, its CEO won't even have time to fart! Much less spending sweet time holding its shareholders hands daily on Hotcopper whereas our own CEO don't even have the time for it.
Ann: VAXINIA and HER-Vaxx featured at the AACR Annual Meeting, page-268
-
- There are more pages in this discussion • 37 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.4¢ |
Change
-0.003(5.26%) |
Mkt cap ! $395.2M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.7¢ | 5.4¢ | $1.444M | 26.24M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 24 | 3824179 | 5.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.5¢ | 172983 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2024 (20 minute delay) ? |
| IMU (ASX) Chart |